1188 related articles for article (PubMed ID: 19632584)
1. Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey.
McDowell DL; Hauptman PJ
J Heart Lung Transplant; 2009 Aug; 28(8):847-50. PubMed ID: 19632584
[TBL] [Abstract][Full Text] [Related]
2. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
3. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
Das M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
[TBL] [Abstract][Full Text] [Related]
4. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
[TBL] [Abstract][Full Text] [Related]
5. Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures.
Hauptman PJ; Swindle JP; Masoudi FA; Burroughs TE
Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):204-11. PubMed ID: 20197509
[TBL] [Abstract][Full Text] [Related]
6. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
Samii SM
Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
[TBL] [Abstract][Full Text] [Related]
7. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
[TBL] [Abstract][Full Text] [Related]
8. Unresolved issues in implantable cardioverter-defibrillator therapy.
Mason PK; DiMarco JP
Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
[TBL] [Abstract][Full Text] [Related]
9. Sudden cardiac death of two heart transplant patients with correctly functioning implantable cardioverter defibrillators.
Marzoa-Rivas R; Perez-Alvarez L; Paniagua-Martin MJ; Ricoy-Martinez E; Flores-Ríos X; Rodriguez-Fernandez JA; Salgado-Fernandez J; Franco-Gutierrez R; Cuenca-Castillo JJ; Herrera JM; Capdevila A; Vazquez P; Castro-Beiras A; Crespo-Leiro MG
J Heart Lung Transplant; 2009 Apr; 28(4):412-4. PubMed ID: 19332273
[TBL] [Abstract][Full Text] [Related]
10. Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapy.
Bernard ML; Gold MR
Heart Fail Clin; 2011 Apr; 7(2):241-50, ix. PubMed ID: 21439502
[TBL] [Abstract][Full Text] [Related]
11. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular implantable electronic devices in athletes.
Do R; Patton KK
Cardiovasc Ther; 2010 Oct; 28(5):327-36. PubMed ID: 20553287
[TBL] [Abstract][Full Text] [Related]
13. [Arrhythmias].
Misaki T; Fukahara K
Kyobu Geka; 2004 Jul; 57(8 Suppl):729-35. PubMed ID: 15362552
[TBL] [Abstract][Full Text] [Related]
14. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.
Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE;
Eur Heart J; 2001 Jul; 22(13):1074-81. PubMed ID: 11428848
[No Abstract] [Full Text] [Related]
15. Audible implantable cardioverter defibrillator alarms detect intermittent conductor discontinuity.
Sheth N; Mahmood K; Singh B; Carter-Adkins D; Pachulski RT
Can J Cardiol; 2002 Apr; 18(4):430-2. PubMed ID: 11992137
[TBL] [Abstract][Full Text] [Related]
16. Recent advancements in the management of sudden cardiac death: implantable antiarrhythmic devices.
Bissett J; Talley JD
J Ark Med Soc; 1995 Jun; 92(1):41-3. PubMed ID: 7615479
[No Abstract] [Full Text] [Related]
17. [Sudden cardiac death, ICD and resynchronization therapy].
Schaumann A; Tack C; Kuck KH
Herz; 2006 Dec; 31(9):857-63. PubMed ID: 17180648
[TBL] [Abstract][Full Text] [Related]
18. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.
Yarnoz MJ; Curtis AB
Cardiol Rev; 2006; 14(6):292-8. PubMed ID: 17053376
[TBL] [Abstract][Full Text] [Related]
19. [From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report].
Gepner K; Sterliński M; Przybylski A; Maciag A; Kołsut P; Szwed H
Kardiol Pol; 2006 Oct; 64(10):1113-7. PubMed ID: 17089244
[TBL] [Abstract][Full Text] [Related]
20. The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death.
Thakor NV; Natarajan A
Med Des Mater; 1991 Mar; 1(3):16-24. PubMed ID: 10147992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
